NON-SEGMENTAL VITILIGO
Clinical trials for NON-SEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Skin puncture techniques tested to restore color in vitiligo patches
Disease control Recruiting nowThis study compares two skin treatment methods—needling and microneedling—both followed by UVB light therapy, to see which works better for restoring skin color in people with stable vitiligo. Researchers will enroll 80 participants aged 15-60 who have had vitiligo for over a yea…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE4 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug trial offers hope for restoring skin color in vitiligo patients
Disease control Recruiting nowThis study is testing an experimental drug called GIA632 for adults with non-segmental vitiligo, a condition that causes loss of skin color. Researchers want to find the most effective and safe dose to reduce white patches on the face and body. The trial involves 210 participants…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New combo therapy trial aims to restore skin color in vitiligo
Disease control Recruiting nowThis study is testing whether a new oral tablet called SHR0302, used alone or with a matching SHR0302 gel, can help restore skin color in adults with non-segmental vitiligo. Researchers will measure changes in the size and appearance of white patches on the face and body over 24 …
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New tablet trial aims to repigment vitiligo patches
Disease control Recruiting nowThis study is testing whether an oral tablet called VC005 can help reduce the white skin patches caused by non-segmental vitiligo, primarily on the face. It will involve about 120 adults and compare the new tablet against a placebo over 24 weeks to see if it's safe and effective.…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug trial aims to restore skin color in vitiligo patients
Disease control Recruiting nowThis study is testing whether a new immune-targeting drug called EI-001 can help improve skin repigmentation in adults with non-segmental vitiligo. About 45 participants will be randomly assigned to receive either the drug or a placebo to compare results. The main goal is to see …
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd. • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC